Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-31

Clinical Trial Update: Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR® [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, tolerability and drug concentrations of CHF 5993 (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide) aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHF 5993 (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide) (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide)
  • QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 1 | Status: COMPLETED